Jeremy M Silverman, PhD
- PROFESSOR | Psychiatry
Research Topics:
Aging, Alzheimer's Disease, Autism, Genetics, Memory, SchizophreniaDr. Jeremy M. Silverman is a Professor in the Department of Psychiatry at the Mount Sinai School of Medicine and the Director of the Mount Sinai Family Studies Research Center which he established in 1988. He received his B.A. from Oberlin College (1978) and his Ph.D. in clinical psychology from New York University (1987). He joined the Psychiatry Department faculty at Mount Sinai in 1987. Dr. Silverman's major research interests pertain to the genetics of psychiatric disorders and, more specifically, the improved delineation of phenotypes and endophenotypes (intermediate phenotypes) associated with successful cognitive aging, dementia, schizophrenia, and other neuropsychiatric conditions in order to strengthen gene finding strategies. Dr. Silverman is also interested in the identification of non-genetic risk and protective factors associated with these conditions.
Multi-Disciplinary Training Areas
Development Regeneration and Stem Cells [DRS], Immunology [IMM], Neuroscience [NEU]Education
BA, Oberlin College
PhD, New York University
MA, New York University
Specific Clinical/Research Interest: My group is especially focused on characterizing phenotypes and endophenotypes in successful cognitive aging, dementia, and schizophrenia for use in molecular genetic studies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Silverman did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.